E. W. M. McDermott

465 total citations
19 papers, 350 citations indexed

About

E. W. M. McDermott is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, E. W. M. McDermott has authored 19 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Pathology and Forensic Medicine and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in E. W. M. McDermott's work include Breast Cancer Treatment Studies (4 papers), Neuroendocrine Tumor Research Advances (3 papers) and Neuroblastoma Research and Treatments (3 papers). E. W. M. McDermott is often cited by papers focused on Breast Cancer Treatment Studies (4 papers), Neuroendocrine Tumor Research Advances (3 papers) and Neuroblastoma Research and Treatments (3 papers). E. W. M. McDermott collaborates with scholars based in Ireland, United States and Netherlands. E. W. M. McDermott's co-authors include Murray F. Brennan, N. J. O’Higgins, Arnold Hill, Leonie S. Young, Thomas B. Crotty, Gabrielle Kelly, Fergal J. Fleming, E. Myers, A Hill and B. Dijkstra and has published in prestigious journals such as Cancer, Cancer Research and British Journal of Cancer.

In The Last Decade

E. W. M. McDermott

17 papers receiving 338 citations

Peers

Countries citing papers authored by E. W. M. McDermott

Since Specialization

Citations

This map shows the geographic impact of E. W. M. McDermott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. W. M. McDermott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. W. M. McDermott more than expected).

Fields of papers citing papers by E. W. M. McDermott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. W. M. McDermott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. W. M. McDermott. The network helps show where E. W. M. McDermott may publish in the future.

Co-authorship network of co-authors of E. W. M. McDermott

This figure shows the co-authorship network connecting the top 25 collaborators of E. W. M. McDermott. A scholar is included among the top collaborators of E. W. M. McDermott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. W. M. McDermott. E. W. M. McDermott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Evaluation of in vivo fish and amphibian endocrine test guideline assays: current status and future needs 2025 ·Environmental Toxicology and Chemistry ·(unknown), Constance A. Mitchell, ZhiChao Dang, Michelle R. Embry, Scott Glaberman, Laurent Lagadic, Scott G. Lynn, (unknown), Ellen Mihaich, E. W. M. McDermott, (unknown), Edward R. Salinas, Heiko L. Schoenfuss, Karen L. Thorpe, Lennart Weltje, James R. Wheeler	0
2	THE USE OF HYOSCINE BUTYLBROMIDE IMPROVES SESSILE SERRATED LESION DETECTION 2022 ·Endoscopy ·(unknown), (unknown), (unknown), Beatrice Nolan, (unknown), (unknown), Hugh Mulcahy, (unknown), Juliette Sheridan, E. W. M. McDermott, Glen Doherty, (unknown), Graham Horgan	0
3	P3-17-03: ADAM17: A Novel Therapeutic Target for Treatment of Triple Negative Breast Cancer. 2011 ·Cancer Research ·(unknown), Maeve Mullooly, (unknown), Stephen F. Madden, E. W. M. McDermott, Andrew Pierce, John Crown, Norma O’Donovan, MJ Duffy	1
4	P5-13-12: Can the Ki67 Proliferation Index Predict the Oncotype DX Recurrence Score in Lymph Node Negative, ER Positive Breast Cancer? 2011 ·Cancer Research ·Aaron Prendergast, Kara Martin, Padraig Doolan, (unknown), Martin Clynes, Denis Evoy, E. W. M. McDermott, (unknown), (unknown)	1
5	Physician's initial impression of elderly breast cancer patients allows appropriate treatment stratification despite lack of quantitative assessment. 2011 ·PubMed ·R S Prichard, (unknown), Denis Evoy, E. W. M. McDermott	2
6	Acute colonic obstruction due to benign prostatic hypertrophy. 2009 ·PubMed ·(unknown), (unknown), Ronan Ryan, (unknown), (unknown), (unknown), N. J. O’Higgins, E. W. M. McDermott	7
7	Cyclooxygenase-2 predicts adverse effects of tamoxifen: a possible mechanism of role for nuclear HER2 in breast cancer patients 2008 ·Endocrine Related Cancer ·Mary F. Dillon, (unknown), Gabrielle Kelly, Aisling M. Redmond, Marie McIlroy, Thomas B. Crotty, E. W. M. McDermott, (unknown), Leonie S. Young	23
8	Diagnostic accuracy of core biopsy for ductal carcinoma in situ and its implications for surgical practice 2006 ·Journal of Clinical Pathology ·(unknown), Cecily Quinn, E. W. M. McDermott, A. O’Doherty, N. J. O’Higgins, A Hill	18
9	Inverse relationship between ER-β and SRC-1 predicts outcome in endocrine-resistant breast cancer 2004 ·British Journal of Cancer ·E. Myers, Fergal J. Fleming, Thomas B. Crotty, Gabrielle Kelly, E. W. M. McDermott, N. J. O’Higgins, Arnold Hill, Leonie S. Young	83
10	Parathyroid localisation--current practice. 2002 ·PubMed ·B. Dijkstra, Ciaran Healy, Louise Kelly, E. W. M. McDermott, A Hill, N. J. O’Higgins	25
11	Pregnancy-associated breast cancer. 2002 ·PubMed ·(unknown), B. Dijkstra, (unknown), E. W. M. McDermott, Arnold Hill, N. J. O’Higgins	8
12	Post-partum ovarian vein thrombosis. 2001 ·PubMed ·(unknown), E. W. M. McDermott, Arnold Hill, (unknown), (unknown)	25
13	The value of sentinel node mapping for staging melanoma. 2001 ·PubMed ·B. Dijkstra, (unknown), Lindsey Kelly, (unknown), E. W. M. McDermott, Michael A. O’Donnell, Conor D. Collins, N. J. O’Higgins	1
14	Cervical exploration for primary hyperparathyroidism--A 25 year experience. 1997 ·PubMed ·(unknown), (unknown), Andrew P. Zbar, (unknown), (unknown), E. W. M. McDermott, N. J. O’Higgins	4
15	Prognostic variables in patients with gastrointestinal carcinoid tumours 1994 ·British journal of surgery ·E. W. M. McDermott, (unknown), Murray F. Brennan	115
16	Perforation through undiagnosed small bowel involvement in primary thyroid lymphoma during chemotherapy 1992 ·Cancer ·E. W. M. McDermott, Noelle Cassidy, (unknown)	19
17	Duodenal carcinoid tumour associated with gastric leiomyoblastoma. 1992 ·PubMed ·D. M. Campbell, E. W. M. McDermott, P J O’Dwyer, (unknown)	2
18	Dietary alcohol intake does not increase the incidence of experimentally induced mammary carcinoma. 1992 ·PubMed ·E. W. M. McDermott, P J O’Dwyer, N. J. O’Higgins	9
19	Metastatic carcinoid tumour presenting as a hepatic pseudocyst 1987 ·Irish Journal of Medical Science (1971 -) ·E. W. M. McDermott	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact